ORBIMED ADVISORS LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 7:22 pm Sale | 2024-09-30 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 0 0.000% | -2,255,000 (Position Closed) | Filing |
| 2024-02-14 7:45 pm Sale | 2023-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 2,255,000 4.500% | -11,000 (-0.49%) | Filing |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | ALX Oncology Holdings Inc. ALXO | ORBIMED ADVISORS LLC | 2,266,000 5.600% | 2,266,000 (New Position) | Filing |